Sarah Duffy

Endometriosis affects ∼5–14% of women/those presumed female at birth, with debilitating symptoms profoundly affecting workforce participation. This cross-sectional survey of 389 employed Australians with self-reported endometriosis examined…

Endometriosis and chronic pelvic pain (CPP) substantially affect work participation and productivity, yet workplace interventions remain largely unevaluated. This study piloted Endo@Work, a co-designed workplace guideline to support employe…

People with endometriosis in Australia predominantly use delta-9 tetrahydrocannabinol cannabis flower and oil products, and cannabidiol preparations, to manage their symptoms, reporting reductions in use of other drugs. It is known that low…

Background: Endometriosis costs Australia $9.7 billion AUD annually, with absenteeism and lost productivity mostly contributing to this cost burden. Previous research has shown how the absence of workplace support(s) for endometriosis sympt…

Endometriosis costs Australia $9.7 billion AUD annually, with most of the cost burden due to absenteeism and lost productivity. Previous research has shown how the absence of workplace support(s) for endometriosis symptom management exacerb…

People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self-reported effectiveness for those accessing medicinal cannabis in Australia. There we…

(1) Objectives: This paper presents a scoping review of global evidence relating to interventions (i.e., policies, practices, guidelines, and legislation) aimed at supporting women to manage menstruation, menstrual disorders, and menopause …